Treatment outcome of multi-drug resistant tuberculosis in a tertiary care hospital in Karachi

被引:0
|
作者
Rao, Nisar Ahmed [1 ]
Irfan, Muhammad [2 ]
Mahfooz, Zeeshan [1 ]
机构
[1] Dow Univ Hlth Sci, Ojha Inst Chest Dis, Dept Pulmonol, Karachi, Pakistan
[2] Aga Khan Univ, Sect Pulm & Crit Care Med, Dept Med, Karachi, Pakistan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess the outcomes of pulmonary multidrug-resistant tuberculosis (MDR-TB) patients treated at Ojha Institute of Chest Diseases (OICD), a reference hospital for TB in Karachi, Pakistan. Methods: Clinical study for the period 1996-2006, with follow-up until June 2007 was performed. All the culture and sensitivity proven cases of MDR pulmonary TB were initially admitted for 3-6 months till the sputum converted negative. Treatment regimen was decided on individual basis, and included 4-6 drugs. Supervised treatment was given to all patients during the hospitalization. After discharge from the hospital, patients were followed at monthly interval at the outpatient department of OICD for 18 months total. Results: Five hundred and seventy nine adult patients (59.93% male) with mean age of 32.44 +/- 12.63 years were studied. All patients had a history of treatment with first line anti-tuberculosis drugs. Treatment was successful in 227 (39.2%). The mortality rate was 27(4.6%) during hospitalization. During admission 83(14.3%) left treatment and 239 (41.2%) were lost to follow-up during treatment. Treatment failure was observed in three patients. Conclusion: The treatment success rate in this study is satisfactory but high default rate is a challenge in the management of MDR tuberculosis (JPMA 59: 694; 2009).
引用
收藏
页码:S75 / S79
页数:5
相关论文
共 50 条
  • [21] Retrospective evaluation of intravenous fosfomycin in multi-drug resistant infections at a tertiary care hospital in Lebanon
    Ballouz, Tala
    Zeenny, Rony M.
    Haddad, Nisrine
    Rizk, Nesrine
    Kanj, Souha S.
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (09): : 1308 - 1313
  • [22] Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital
    Jung, R
    Fish, DN
    Obritsch, MD
    MacLaren, R
    JOURNAL OF HOSPITAL INFECTION, 2004, 57 (02) : 105 - 111
  • [23] Role of therapeutic drug monitoring in the treatment of multi-drug resistant tuberculosis
    Maranchick, Nicole F.
    Peloquin, Charles A.
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2024, 36
  • [24] Multi-Drug Resistant Pulmonary Tuberculosis
    Joshi, J. M.
    Gothi, D.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2006, 2 (01) : 53 - 57
  • [25] Multi-drug resistant tuberculosis in HIV
    Okelo, G. B. A.
    DISCOVERY AND INNOVATION, 2005, 17 : 38 - 39
  • [26] Facing multi-drug resistant tuberculosis
    Sotgiu, Giovanni
    Migliori, Giovanni Battista
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 32 : 144 - 148
  • [27] Multi-drug Resistant Childhood Tuberculosis
    Singh, Varinder
    Kaur, Satnam
    INDIAN JOURNAL OF PEDIATRICS, 2011, 78 (04): : 456 - 463
  • [28] Multi-drug Resistant Childhood Tuberculosis
    Varinder Singh
    Satnam Kaur
    The Indian Journal of Pediatrics, 2011, 78 : 456 - 463
  • [29] A safety evaluation of bedaquiline for the treatment of multi-drug resistant tuberculosis
    Cohen, Karen
    Maartens, Gary
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (10) : 875 - 882
  • [30] Pharmacology of emerging drugs for the treatment of multi-drug resistant tuberculosis
    Johnson, Tanner M.
    Rivera, Christina G.
    Lee, Grace
    Zeuli, John D.
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2024, 37